Ehsan Jabbarzadeh, PhD
Professor, Entrepreneur, Venture Capitalist @ IAG
Dr. Jabbarzadeh was a co-founder and CEO of Obsidio, Inc, which was acquired by Boston Scientific in 2022.
He concurrently holds the position of Full Professor of Chemical and Biomedical Engineering and Director of Engineering Entrepreneurship at the University of South Carolina. His training includes a Ph.D. in Chemical Engineering from Drexel University, a Postdoctoral Fellowship in Bioengineering at the California Institute of Technology, and an MBA in Finance and Entrepreneurship at the University of Southern Carolina, Marshall School of Business. He has authored over 30 peer-reviewed research papers and 10 issued and pending patents.
Dr. Jabbarzadeh currently works in Venture Capital @ IAG.